Mestranol Market Size, Segments, and Growth Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Mestranol Market covers analysis By Type (Kit, Tablet); End User (Abnormal, Uterine Bleeding, Endometriosis, Hypermenorrhea, Menstrual Cramps, Polycystic Ovarian Syndrome) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00019311
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Mestranol Market is expected to register a CAGR of 11.1% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.

The research report on the Mestranol Market is segmented by type into oral contraceptive formulations and hormonal therapy drugs. Applications analyzed include birth control, hormonal replacement therapy, and menstrual regulation. End-users include pharmaceutical companies, hospitals, gynecological clinics, and healthcare providers. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses. This report explores the growing use of mestranol in contraceptive formulations, its role in hormone therapy, and the increasing demand for combination oral contraceptives.

Purpose of the Report

The report Mestranol Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Mestranol Market Segmentation

Type

  • Kit
  • Tablet

End User

  • Abnormal
  • Uterine Bleeding
  • Endometriosis
  • Hypermenorrhea
  • Menstrual Cramps
  • Polycystic Ovarian Syndrome

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Mestranol Market: Strategic Insights

mestranol-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Mestranol Market Growth Drivers

  • Rising Demand for Oral Contraceptives: Mestranol is used primarily as an estrogen compound in oral contraceptives, usually in combination with progestins. An ever-increasing demand for effective and convenient birth control options continues to spur the mestranol market. The steady rise in demand for oral contraceptives is attributed to, among other things, the growing emphasis on reproductive health, especially that of women, since these methods are convenient, effective, and reversible. Expansion in contraceptive use has also been fueled by increasing education and awareness about family planning campaigns and an increasing number of women entering the workforce and hence seeking reproductive control. Since mestranol is the core material in a number of oral contraceptives, this fact does translate into a significant catalyst for the market.
  • Awareness around women's health and family planning: Awareness around women's health and family planning has seen a significant rise in developed and developing regions. The sight and sound of government initiatives and non-profit organizations have continued to conduct education regionally on reproductive rights, menstrual health, and contraceptives. The more educated and accessible females get in countries with higher penetration, the higher the demand for birth control methods such as oral contraceptives, immediately increasing the potential market of mestranol-based formulations. This has been further exacerbated by women's empowerment movements and increasing acceptance of contraceptive use for demand control for family size and timing of pregnancies.
  • Availability of Combination Therapy: Mestranol is most often used in conjunction with other female hormones, usually progestins, as a combination oral contraceptive. This combination has provided a more balanced hormone profile with fewer side effects compared to estrogen alone while being more effective against pregnancy. Combination therapies that offer higher efficacies in preventing pregnancies, plus other benefits like reducing PCOS-associated symptoms and regulation of the cycle, have always been demanded. As women continue to gain awareness around various benefits of these combination oral contraceptives, just as demand for mestranol-based pills expectedly tracks high.

Mestranol Market Future Trends

  • Shifting Towards Low-Dose Hormonal Contraceptives: Among the key trends taking place in the contraceptive market are those pertaining to the increasing preference for low-dose hormonal contraceptives. Many oral contraceptives in this class utilize the estrogen mestranol since lower doses with this particular estrogen minimize side effects such as nausea, mood swings, and weight gain. More and more women on birth control prefer these low-dose formulations since they tend to be better tolerated while still being effective. Mestranol continues to be popular in combinatory pills, thus nurturing its existence in the contraceptive market.
  • Preference for Non-Estrogen Birth Control Methods:
    So far, oral contraceptives based on mestranol have retained some popularity, but preferences toward non-estrogen birth control-methods are on the rise. These alternatives, often progestin-only pills, implants, and IUDs, are mostly favored for women who report side effects with estrogen or for those who cannot take it (e.g., smokers, women with a history of blood clots, or above 35). The emerging trend is indeed a threat for the mestranol market, but combination oral contraceptives like mestranol will continue to maintain a significant share of the market because of their advantages of being convenient, effective, and versatile.
  • Trend of Personalised Medicine: Personalized medicine is gaining popularity in various therapeutic fields, including contraception. As a result, providers of healthcare look to individualize contraceptive options according to a given patient's health requirements, preferences, and lifestyle factors. As hormonal contraceptives become increasingly numerous and diverse, including those containing mestranol, consideration is being given to helping women select the most appropriate for them according to their medical conditions and reproductive objectives. The personalized approach to the choice of contraception may include, among other things, hormonal profiles, immediate side effects, and ease of use-things that commonly affect the choice for a drug such as a mestranol-containing pill.

Mestranol Market Opportunities

  • Research on Extended-Release and Long-Acting Formulations: There is ongoing research into the development of extended-release and long-acting formulations of hormonal contraceptives. While mestranol is primarily used in oral tablets, new delivery methods, such as transdermal patches, implants, or injectables, could offer opportunities for the inclusion of mestranol in these advanced formulations. This innovation would improve convenience for users and expand mestranol’s role in contraception beyond traditional oral forms, potentially driving growth in the market.
  • Combination Therapies for Other Health Conditions:
    Mestranol is not only used for contraception but also for managing conditions such as acne, endometriosis, and menstrual irregularities. Expanding its use in the treatment of other health issues presents an opportunity for market growth. The development of combination therapies that address both contraception and other conditions (e.g., reducing menstrual cramps or regulating irregular cycles) could lead to increased demand. Healthcare providers may recommend mestranol-based therapies for multiple health conditions, thereby enhancing its therapeutic reach.
  • Technological Advancements in Manufacturing:
    Advancements in pharmaceutical manufacturing technologies, such as improved tablet coatings and more efficient production processes, could lower the cost of mestranol-based contraceptives, making them more affordable. Furthermore, innovations in the formulation of mestranol, including more stable or longer-lasting versions, could drive adoption. The ability to manufacture high-quality, cost-effective products at a larger scale presents a significant opportunity for increasing the availability of mestranol-based contraceptives, particularly in price-sensitive markets.

Mestranol Market Regional Insights

The regional trends and factors influencing the Mestranol Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Mestranol Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

mestranol-market-global-geography
  • Get the Regional Specific Data for Mestranol Market

Mestranol Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 11.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Kit
  • Tablet
By End User
  • Abnormal
  • Uterine Bleeding
  • Endometriosis
  • Hypermenorrhea
  • Menstrual Cramps
  • Polycystic Ovarian Syndrome
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • JohnsonandJohnson
  • TevaPharmaceuticalIndustriesLtd
  • PfizerInc
  • ASKAPharmaceuticalCoLtd
  • LGMPharma
  • MerckKGaA
  • GlaxoSmithKlinePlc
  • SanofiSA
  • EliLillyandCompany

  • Mestranol Market Players Density: Understanding Its Impact on Business Dynamics

    The Mestranol Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Mestranol Market are:

    1. JohnsonandJohnson
    2. TevaPharmaceuticalIndustriesLtd
    3. PfizerInc
    4. ASKAPharmaceuticalCoLtd
    5. LGMPharma
    6. MerckKGaA

    Disclaimer: The companies listed above are not ranked in any particular order.


    mestranol-market-cagr

    • Get the Mestranol Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Mestranol Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Mestranol Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What is the expected CAGR of the Mestranol Market?

    The Mestranol Market is expected to register a CAGR of 11.1% from 2025-2031.

    What are the driving factors impacting the Mestranol Market?

    The major driving factors supporting the Mestranol Market growth are- Rising Demand for Oral Contraceptives,Awareness around women's health and family planning, and Availability of Combination Therapy

    What are the future trends in the Mestranol Market?

    Key Future Trends in the Mestranol Market are- Shifting Towards Low-Dose Hormonal Contraceptives, Preference for Non-Estrogen Birth Control Methods, and Trend of Personalised Medicine

    Which are the key players in the Mestranol Market?

    Key companies in Mestranol Market are - JohnsonandJohnson , TevaPharmaceuticalIndustriesLtd , PfizerInc , ASKAPharmaceuticalCoLtd , LGMPharma , MerckKGaA , GlaxoSmithKlinePlc , SanofiSA , EliLillyandCompany

    What are the deliverable formats of the Mestranol Market?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1.Johnson and Johnson
    2.Teva Pharmaceutical Industries Ltd.
    3.Pfizer Inc.
    4.ASKA Pharmaceutical Co., Ltd.
    5.LGM Pharma.
    6.Merck KGaA
    7.GlaxoSmithKline plc
    8.Sanofi S.A.
    9.Eli Lilly and Company
    10.Thai Nakorn Patana Co., Ltd.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo